Trial Profile
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Malignant-mesothelioma
- Focus Expanded access; Therapeutic Use
- Sponsors Eli Lilly and Company
- 16 Jun 2017 New trial record